Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Orexin receptor type 2 | ||
Ligand | BDBM386112 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Measurement of Orexin Type 2 Receptor Agonist Activity | ||
EC50 | 4100±n/a nM | ||
Citation | Fujimoto, T; Rikimaru, K; Fukuda, K; Sugimoto, H; Matsumoto, T Substituted piperidine compound and use thereof US Patent US10508083 Publication Date 12/17/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Orexin receptor type 2 | |||
Name: | Orexin receptor type 2 | ||
Synonyms: | HCRTR2 | Hypocretin receptor type 2 | OX2R_HUMAN | Orexin receptor type 2 (OR 2) | Orexin receptor type 2 (OR-2) | Orexin receptor type 2 (OX2) | Orexin receptor type 2 (OX2R) | Orexin receptor type 2 (OxR2) | Ox-2-R | Ox2-R | ||
Type: | Protein | ||
Mol. Mass.: | 50710.53 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O43614 | ||
Residue: | 444 | ||
Sequence: |
| ||
BDBM386112 | |||
n/a | |||
Name | BDBM386112 | ||
Synonyms: | N-(cis-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-(3- phenylpropanoyl)piperidin-3- yl)methanesulfonamide | US10287305, Example 54 | US10508083, Example 54 | US11292766, Example 54 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H40N2O4S | ||
Mol. Mass. | 464.661 | ||
SMILES | CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)CCc1ccccc1)NS(C)(=O)=O |r,wU:3.2,6.9,11.11,12.29,(-6,4.62,;-4.67,5.39,;-4.67,6.93,;-3.33,4.62,;-3.33,3.08,;-2,2.31,;-.67,3.08,;-.67,4.62,;-2,5.39,;.67,2.31,;.67,.77,;2,,;3.33,.77,;4.67,,;4.67,-1.54,;3.33,-2.31,;2,-1.54,;.67,-2.31,;.67,-3.85,;-.67,-1.54,;-2,-2.31,;-2,-3.85,;-3.33,-4.62,;-3.33,-6.16,;-2,-6.93,;-.67,-6.16,;-.67,-4.62,;3.33,2.31,;4.67,3.08,;6,2.31,;3.9,4.41,;5.44,4.41,)| | ||
Structure |